Linzess tablets 0.25mg, from Astellas Pharma, contain Linaclotide (YJ code: 2399017F1020, standard: 0.25 mg 1 tablet). This medication is indicated for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation in adults.
Linzess tablets 0.25mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).
